Vaxcyte, Inc. - 10-Q Filing

Vaxcyte, Inc. reports third quarter 2026 financial results and updates on equity incentive plans. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)

SEC EDGAR ·

Tickers: $PCVX

Read the full article at SEC EDGAR

More Regulatory news